Delivery Order 75FCMC19D0080-75FCMC26F0074
- The Centers for Medicare and Medicaid Services (CMS) awarded a delivery order valued at $15.5 million to ABT Global LLC on August 16, 2024, for the evaluation of the cell and gene therapy access model. This effort falls under the Research, Measurement, Assessment, Design, and Analysis (RMADA) 2 indefinite delivery vehicle and will be performed in Windsor Mill and Milford Mill, Maryland. The contract employs a cost-plus-fixed-fee pricing structure and is scheduled for completion by August 15,...
- This federal contract award was issued by the Centers for Medicare and Medicaid Services (CMS), a civilian agency within the U.S. Department of Health and Human Services (HHS), to ABT Associates Inc., a global research and consulting firm. The $10,764,808.00 cost-plus-fixed-fee delivery order contract is a task order under the RMADA 2 Indefinite Delivery/Indefinite Quantity (IDIQ) contract, which provides research and analytical services to support CMS program evaluation initiatives. The...
- This is a Cost Plus Fixed Fee delivery order contract awarded by the Centers for Medicare and Medicaid Services (CMS), a civilian agency within the U.S. Department of Health and Human Services (HHS), to prime contractor ABT Associates Inc. The contract, valued at $4,571,230.00, is for the ACO AIM EVALUATION project and is part of the Research Measurement Assessment Design and Analysis (RMADA) Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle. The contract does not have a...
- This is a $14,295,071 federal delivery order contract awarded to ABT Global LLC by the Centers for Medicare and Medicaid Services (CMS). The contract is part of CMS's Professional Services Schedule (PSS) contract vehicle and is for professional support services. The contract has no set-aside designation. ABT Global LLC, a subsidiary of the global consulting firm ABT Associates Inc., is the prime contractor. Major subcontractors include Mosimtec LLC, TMF Health Quality Institute, Alliant Health...
- This is a $11,784,062.66 cost-plus-fixed-fee delivery order contract awarded by the Centers for Medicare and Medicaid Services (CMS) to ABT Global LLC, a subsidiary of ABT Associates Inc. The contract is for the development, maintenance, and support of hospital clinical quality measures in support of the ARRA HITECH program. There is no set-aside designation for this award. ABT Associates Inc. is a global research and consulting firm with over 50 years of experience supporting federal agencies...
- This federal contract award is for strategic Medicaid and CHIP managed care monitoring, oversight, and technical assistance. It was awarded by the Centers for Medicare and Medicaid Services (CMS) to the prime contractor, ABT Global LLC, on a cost-plus-fixed-fee basis. The $35,606,364 contract is part of the larger Research, Measurement, Assessment, Design, and Analysis 2 (RMADA 2) vehicle. No set-aside designation was used for this award. ABT Global LLC, a subsidiary of the global consulting...
- This federal contract was awarded by the Centers for Medicare and Medicaid Services (CMS), a division of the U.S. Department of Health and Human Services (HHS), to ABT Associates Inc. to evaluate the Medicaid Innovation Accelerator Program's technical assistance activities. The $5,440,298 cost-plus-fixed-fee contract, which is part of CMS's Research, Measurement, Assessment, Design, and Analysis (RMADA) indefinite delivery/indefinite quantity (IDIQ) contract vehicle, does not have a set-aside...
- This is a federal contract award to ABT Associates Inc., a global research and consulting firm, by the Centers for Medicare and Medicaid Services (CMS), which is part of the U.S. Department of Health and Human Services (HHS). The contract is for research and development services related to health services, with a cost-plus-fixed-fee pricing type. The contract has a ceiling value of $918,542.00 and a period of performance ending on May 31, 2010. The contract is not set-aside and was awarded on...
- The Centers for Medicare & Medicaid Services (CMS) awarded ABT Global LLC a delivery order valued at $20.2M under the Research, Measurement, Assessment, Design, and Analysis (RMADA) 2 indefinite delivery vehicle to conduct a comprehensive evaluation of the Integrated Care for Kids (INCK) initiative, a state-based program designed to improve healthcare outcomes for vulnerable pediatric populations. The contract, awarded on August 18, 2020, with an ultimate completion date of August 17,...
- ABT Global LLC, a subsidiary of the global consulting firm ABT Associates Inc., was awarded a delivery order valued at approximately $31 million by the Centers for Medicare and Medicaid Services (CMS) on November 19, 2023, for the development and maintenance of home health quality measurement instruments, value-based purchasing models, and hospice assessment tools under the Measure and Instrument Development and Support (MIDS 2) indefinite delivery vehicle. The contract, which operates on a...
- 75FCMC19D0080Indefinite Delivery Contract
- 75FCMC19D0080-75FCMC26F0074Delivery Order
The Centers for Medicare and Medicaid Services (CMS) awarded a delivery order valued at $6.52 million to ABT Global LLC for implementation and monitoring of the Make America Healthy Again (MAHA) Enhancing Lifestyle & Evaluating Value-Based Approaches Through Evidence (ELEVATE) Model. This initiative seeks to gather innovative proposals from diverse stakeholders to advance value-based healthcare approaches and improve population health outcomes. The contract, awarded on April 20, 2026, with performance through April 19, 2032, operates under a cost-plus-fixed-fee pricing structure with no set-aside designation, reflecting open competition. Work will be performed at ABT Global's headquarters in North Bethesda, Maryland. This delivery order is issued under the Research, Measurement, Assessment, Design, and Analysis 2 (RMADA 2) master IDIQ vehicle. ABT Global LLC, a subsidiary of ABT Associates Inc., brings substantial experience in healthcare evaluation and evidence-based research to this engagement. The firm has delivered extensive program evaluation and quality measurement services to CMS on prior initiatives, including cell and gene therapy evaluations and quality measurement development. ABT Global's proven track record across federal health agencies, including the Centers for Disease Control and Prevention and the Department of Health and Human Services, positions it to effectively support the ELEVATE Model's objectives of identifying and implementing innovative, evidence-based approaches to enhance health outcomes through value-based care delivery mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9m | 4/16/26 |